H7N9 Mix and Match With MF59 in Healthy Adults

NCT01938742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

700

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
DRUG: MF59

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)